Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_provenance.
- NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_assertion description "[In this study, we examined if treatment with sorafenib, a potent inhibitor of Raf kinase and VEGF receptor, could reverse the resistant phenotype in tumor and tumor-associated endothelial cells, thereby enhancing the therapeutic efficacy of currently used chemoradiation treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_provenance.
- NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_assertion evidence source_evidence_literature NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_provenance.
- NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_assertion SIO_000772 21551262 NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_provenance.
- NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_assertion wasDerivedFrom befree-20140225 NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_provenance.
- NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_assertion wasGeneratedBy ECO_0000203 NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_provenance.
- befree-20140225 importedOn "2014-02-25" NP666356.RAT-bHyPj1mrHcbvJtl2AJK8MNCJBdVBeI5F4DHBxGdyY130_provenance.